Clinical Trial Update: Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 feasibility study of BPX-04 topical minocycline gel completed in patients with moderate to severe papulopustular rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• BPX-04 Topical Minocycline Gel (minocycline)

Snippet

Sponsor: BioPharmX, Inc. | Conditions: Moderate to Severe Papulopustular Rosacea | Phase 1, Phase 2 | Status: COMPLETED